Abstract:Abstract. The present case study documents an autopsy case of granulocyte-colony stimulating factor (G-CSF)-producing mucinous cystic neoplasm (MCN), with an associated invasive carcinoma of the pancreas. A 65-year-old woman presented to Omuta City Hospital (Omuta Japan) with a primary complaint of abdominal pain. Multiple liver nodules and a pancreatic cyst were detected upon abdominal computed tomography. Initially, liver abscess was suspected as the patient exhibited leukocytosis and elevated C-reactive pro… Show more
“…Moreover, we have shown that patients with cervical intraepithelial neoplasia exhibited an increase in the frequency of circulating CD66b + low density neutrophils, again indicating systemic effects of these lesions, even before progressing to cancer [17]. Besides HPV associated cancers, other types of solid tumors can induce leukocytosis, including pancreas, non-small lung and colorectal cancer [41–43]. Leukocytosis can lead to the accumulation of MDSC that inhibit T cell responses, and by extension hamper anti-tumor cell cytotoxic activity.…”
Cervical cancer, caused by high oncogenic risk Human Papillomavirus (HPV) infection, continues to be a public health problem, mainly in developing countries. Using peptide phage display as a tool to identify potential molecular targets in HPV associated tumors, we identified α-mannosidase, among other enriched sequences. This enzyme is expressed in both tumor and inflammatory compartment of the tumor microenvironment. Several studies in experimental models have shown that its inhibition by swainsonine (SW) led to inhibition of tumor growth and metastasis directly and indirectly, through activation of macrophages and NK cells, promoting anti-tumor activity. Therefore, the aim of this work was to test if swainsonine treatment could modulate anti-tumor immune responses and therefore interfere in HPV associated tumor growth. Validation of our biopanning results showed that cervical tumors, both tumor cells and leukocytes, expressed α-mannosidase.
Ex vivo
experiments with tumor associated macrophages showed that SW could partially modulate macrophage phenotype, decreasing CCL2 secretion and impairing IL-10 and IL-6 upregulation, which prompted us to proceed to
in vivo
tests. However,
in vivo
, SW treatment increased tumor growth. Investigation of the mechanisms leading to this result showed that SW treatment significantly induced the accumulation of myeloid derived suppressor cells in the spleen of tumor bearing mice, which inhibited T cell activation. Our results suggested that SW contributes to cervical cancer progression by favoring proliferation and accumulation of myeloid cells in the spleen, thus exacerbating these tumors systemic effects on the immune system, therefore facilitating tumor growth.
“…Moreover, we have shown that patients with cervical intraepithelial neoplasia exhibited an increase in the frequency of circulating CD66b + low density neutrophils, again indicating systemic effects of these lesions, even before progressing to cancer [17]. Besides HPV associated cancers, other types of solid tumors can induce leukocytosis, including pancreas, non-small lung and colorectal cancer [41–43]. Leukocytosis can lead to the accumulation of MDSC that inhibit T cell responses, and by extension hamper anti-tumor cell cytotoxic activity.…”
Cervical cancer, caused by high oncogenic risk Human Papillomavirus (HPV) infection, continues to be a public health problem, mainly in developing countries. Using peptide phage display as a tool to identify potential molecular targets in HPV associated tumors, we identified α-mannosidase, among other enriched sequences. This enzyme is expressed in both tumor and inflammatory compartment of the tumor microenvironment. Several studies in experimental models have shown that its inhibition by swainsonine (SW) led to inhibition of tumor growth and metastasis directly and indirectly, through activation of macrophages and NK cells, promoting anti-tumor activity. Therefore, the aim of this work was to test if swainsonine treatment could modulate anti-tumor immune responses and therefore interfere in HPV associated tumor growth. Validation of our biopanning results showed that cervical tumors, both tumor cells and leukocytes, expressed α-mannosidase.
Ex vivo
experiments with tumor associated macrophages showed that SW could partially modulate macrophage phenotype, decreasing CCL2 secretion and impairing IL-10 and IL-6 upregulation, which prompted us to proceed to
in vivo
tests. However,
in vivo
, SW treatment increased tumor growth. Investigation of the mechanisms leading to this result showed that SW treatment significantly induced the accumulation of myeloid derived suppressor cells in the spleen of tumor bearing mice, which inhibited T cell activation. Our results suggested that SW contributes to cervical cancer progression by favoring proliferation and accumulation of myeloid cells in the spleen, thus exacerbating these tumors systemic effects on the immune system, therefore facilitating tumor growth.
“…However, no studies have evaluated the pattern of necrosis in G-CSF-producing tumors, and further research is needed in this respect. There are many case reports of G-CSF-producing tumors initially treated with antibiotics because of misdiagnosis as abscesses [ 5 , 39 – 46 ]. In our cases 3 and 4, the imaging findings were very similar to liver abscess (Fig.…”
Granulocyte colony-stimulating factor (G-CSF)-producing tumors have an aggressive clinical course. Here, we report five cases of G-CSF-producing tumors and review the literature, focusing on imaging findings related to tumor-produced G-CSF. In addition to our cases, we identified 30 previous reports of G-CSF-producing tumors on which 18F-fluorodeoxyglucose positron emission tomography (FDG-PET)/CT, bone scintigraphy, or evaluation of bone marrow MR findings was performed. White blood cell count, serum C-reactive protein, and serum interleukin-6 were elevated in all cases for which these parameters were measured. G-CSF-producing tumors presented large necrotic masses (mean diameter 83.2 mm, range 17–195 mm) with marked FDG uptake (mean maximum standardized uptake value: 20.09). Diffuse FDG uptake into the bone marrow was shown in 28 of the 31 cases in which FDG-PET/CT was performed. The signal intensity of bone marrow suggested marrow reconversion in all seven MRI-assessable cases. Bone scintigraphy demonstrated no significant uptake, except in two cases with bone metastases. Splenic FDG uptake was increased in 8 of 10 cases in which it was evaluated. These imaging findings may reflect the effects of tumor-produced G-CSF. The presence of G-CSF-producing tumors should be considered in patients with cancer who show these imaging findings and marked inflammatory features of unknown origin.
“…Renal lesions include aCN, [24][25][26][27][28][29][30] and the related lesion, MEST of the kidney, 24,26,27,[29][30][31][32][33] as well as angiomyolipoma with epithelial cysts. [34][35][36] There is also mucinous cystic neoplasm of the pancreas [37][38][39][40][41][42][43][44][45]65 and of the liver. 39,42,46,47 A common theme in these lesions is a female predominance and reference to the stroma around the cysts as being "ovarian" or "Müllerian" in appearance.…”
Section: Discussionmentioning
confidence: 99%
“…5,23 In contrast, a female predominance is also known to occur in a small number of pathologic lesions, not considered to be part of the DICER1 tumor predisposition syndrome, and not involving the female reproductive system. Most are renal lesions, including adult cystic nephroma (aCN), [24][25][26][27][28][29][30] mixed epithelial-stromal tumor (MEST) of the kidney, 24,26,27,[29][30][31][32][33] and angiomyolipoma with epithelial cysts; [34][35][36] but there are other non-renal lesions, including mucinous cystic neoplasm of the pancreas [37][38][39][40][41][42][43][44][45] and of the liver. 39,42,46,47 The strong predominance of female patients raises the question as to whether these lesions are, at least in part, hormonally driven.…”
mentioning
confidence: 99%
“…Support for this concept comes from the expression of estrogen receptors (ERs) considered to be characteristic or even diagnostic for the previously mentioned entities. [24][25][26][27][28][29][30][31][32][33][34][35][36]38,39,[41][42][43][44][45][46][47] Furthermore, these studies show that it is the stromal/mesenchymal component of the lesions that expresses ER, as documented by immunohistochemistry.…”
DICER1 tumor predisposition syndrome results from pathogenic variants in DICER1 and is associated with a variety of benign and malignant lesions, typically involving kidney, lung, and female reproductive system. Over 70% of sarcomas in DICER1 tumor predisposition syndrome occur in females. Notably, pediatric cystic nephroma (pCN), a classic DICER1 tumor predisposition syndrome lesion, shows estrogen receptor (ER) expression in stromal cells. There are also renal, hepatic, and pancreatic lesions unassociated with DICER1 tumor predisposition syndrome that have an adult female predominance and are characterized/defined by ER-positive stromal cells. Except for pCN, the expression of ER in DICER1-associated lesions remains uninvestigated. In the present study, ER expression was assessed by immunohistochemistry in 89 cases of DICER1-related lesions and 44 lesions lacking DICER1 pathogenic variants. Expression was seen in stromal cells in pCN and pleuropulmonary blastoma (PPB) types I and Ir, whereas anaplastic sarcoma of kidney and PPB types II and III were typically negative, as were other solid tumors of non-Müllerian origin. ER expression was unrelated to the sex or age of the patient. Expression of ER showed an inverse relationship to preferentially expressed antigen in melanoma (PRAME) expression; as lesions progressed from cystic to solid (pCN/anaplastic sarcoma of kidney, and PPB types I to III), ER expression was lost and (PRAME) expression increased. Thus, in DICER1 tumor predisposition syndrome, there is no evidence that non-Müllerian tumors are hormonally driven and antiestrogen therapy is not predicted to be beneficial. Lesions not associated with DICER1 pathogenic variants also showed ER-positive stromal cells, including cystic pulmonary airway malformations, cystic renal dysplasia, and simple renal cysts in adult kidneys. ER expression in stromal cells is not a feature of DICER1 perturbation but rather is related to the presence of cystic components.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.